Note 12 - Contingent liabilities and pending litigation
| 2007 | 2006 | ||
| DKK million | DKK million | ||
| Contingent liabilities | |||
| Rental and leasing commitments expiring within the following periods from the balance sheet date: | |||
| Within 1 year | 17 | 19 | |
| Between 1 and 2 years | 13 | 14 | |
| Between 2 and 3 years | 10 | 11 | |
| Between 3 and 4 years | 9 | 10 | |
| Between 4 and 5 years | 7 | 9 | |
| After 5 years | 15 | 22 | |
| Total contingent liabilities at December 31 | 71 | 85 | |
| The above rental and leasing commitments are related to non-cancelable operational leasing contracts. | |||
| The following amounts have been recognized in the income statement for Novozymes A/S in respect of operational leasing and rentals | 44 | 38 | |
| 2007 | 2006 | ||
| DKK million | DKK million | ||
| Other contingent liabilities | |||
| Contractual obligations to third parties relating to capital expenditure | 63 | 51 | |
| Other guarantees and commitments to third parties | 41 | 96 | |
| Other guarantees and commitments to affiliated companies | 590 | 157 | |
| Pending litigation and arbitration | |||
| Reference is made to Note 27 in the consolidated financial statements concerning pending cases. | |||
| Liability for the debts and obligations of Novo Nordisk A/S | |||
| Reference is made to Note 27 in the consolidated financial statements concerning liability for the debts and obligations of Novo Nordisk A/S. | |||
